An underground economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.
Investigational Drug Acquiring Popularity Via Social Media
Retatrutide, which remains in research studies, is being promoted by social media influencers for its alleged fat-burning properties. Followers are urged to contact these profiles directly for supplier links, while also receiving promotional offers.
Active Commerce on Messaging Platforms
Additionally, a robust trade exists on Telegram, where communities with thousands of participants share “before and after” images, administration instructions and assertions of rapid UK delivery. Sellers promote the substance there before redirecting buyers to other platforms for transactions.
Understanding Retatrutide
Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.
Healthcare Professionals Voice Worries
However, physicians and chemists have warned that the distribution of what is still an unlicensed drug in the United Kingdom is worrisome and could result in users injecting substances of unknown origin.
Several experts said the popularity for the experimental drug could be linked to the rising price of licensed weight loss treatments such as Mounjaro.
Regulatory Position and Enforcement
Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Some influencers try to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still breach pharmaceutical, marketing, and customer regulations, potentially leading to fines, legal action or imprisonment.
Platform Reaction and Material Elimination
Based on the social media company, the service has removed violative material and prohibited associated keywords and query recommendations. The organization said it was dedicated to keeping the platform secure and allocating resources in strengthening compliance measures.
Digital Marketplace Activities
Investigations also found communities with up to 9,000 participants selling retatrutide using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly displays channels with thousands of members, populated with images of slimming results, glowing reviews and detailed instructions for mixing or administering at home.
Within moments of joining one community, a seller shared contact information, where most purchases take place. The seller sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another provided a image of a supposed testing documentation. None asked about weight, medical conditions or previous experience.
Product Details and Pricing
Within these communities, messages display black plastic parcels with Royal Mail labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, prepared at home with purified liquid, or pre-filled pens typically priced at 160 pounds for 20mg. When asked how long a injector should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”.
Platform Moderation and Security Measures
A representative for the messaging service said it actively monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are injecting materials they cannot confirm. Even if the research behind retatrutide is valid, these online products may not include what they claim,” said Jason Murphy, the head of pharmacy at a pharmacy service.
A medical professional of an online medical service connected the surge in interest to recent cost increases for approved slimming medications such as Mounjaro. “With prices rising, patients are using online platforms. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.
Her staff has previously seen individuals harmed by self-injection from unverified suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be impure or incorrectly dosed.”
Manufacturer Statement
A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can market [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental product not yet authorized … may subject patients to possibly serious health risks”.
